-
Money9 Covid25 Index continues to outperform Nifty50, Nifty Pharma
Money9 Covid25 Index advanced 2.78% while Nifty50 and Nifty Pharma logged gains of 0.82% and 2.57%, respectively
-
Money9 Covid25 Index: Check out its performance
In the current week, benchmark index Nifty 50 ended with losses of 1% whereas Money9 Covid25 Index fell 0.7%
-
Launching Money9 Covid25 Index: These 25 Covid-stocks are beating Dalal Street
The index consists of 25 Covid-stocks broadly categorised into five verticals of the healthcare industry — vaccine manufacturers, pharma companies,
